Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-06-16

FDA Approved: AUROVELA 1/20 — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approves AUROVELA 1/20 as an original application generic combined oral contraceptive containing norethindrone acetate and ethinyl estradiol. This approval …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AUROVELA 1/20 (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL)

Snippet

ORIG AP for AUROVELA 1/20 (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL)